Kerry Group acquires Colombian natural functional systems company Proexcar

LONDON, UK: Kerry Group plc, the global taste & nutrition company, has acquired 100% of the share capital of Proexcar S.A.S. for an initial consideration of US$44 million subject to routine closing adjustments, with a potential additional payment of up to US$18 million payable in 2025 based on achieving earn-out conditions.

Proexcar is a Colombian company with c. 120 employees, that specializes in natural functional systems technologies, which can deliver clean label solutions into protein applications. The company has a strong presence in the Andean region and serves customers across Latin America.

The acquisition strengthens Kerry’s offering and leadership position within the overall LATAM meat market, while also providing a platform for strategic development within the Andean region.

Edmond Scanlon, CEO of Kerry Group, said: “We are delighted to welcome Proexcar to the Kerry family. This acquisition is aligned with our strategic growth priorities and enhances our capabilities and solutions portfolio in the fast-growing clean label meat sector. Proexcar’s expertise and technologies will complement our existing taste and nutrition portfolio and enable us to offer more value-added solutions to our customers in Latin America and beyond.”

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. It innovates with its customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. It has a global RD&A team of 1,100+ food scientists and an extensive global footprint that enable it to solve its customers’ complex challenges with differentiated solutions. At Kerry, it is driven to be its customers’ most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030.

Kerry Group to sell its Sweet Ingredients Portfolio IRCA for €500 million

Kerry Group reaches agreement to acquire Niacet for €853 million

Leave a Reply

Your email address will not be published. Required fields are marked *